Growth factors and craniofacial surgery.

Area of Science:

• Craniofacial Surgery
• Regenerative Medicine
• Biotechnology

Background:

• Craniofacial surgery encompasses trauma, aesthetics, congenital deformities, and tissue regeneration, involving both soft and hard tissues.
• Technological advancements have improved clinical outcomes, driving the pursuit of predictable tissue regeneration.
• A growing array of biological agents is becoming available to surgeons.

Purpose of the Study:

• To critically evaluate the role and impact of biological factors in craniofacial surgery.
• To focus on growth factor technology and its application in bone tissue regeneration.
• To assess the safety, logic, and timeliness of using recombinant DNA-engineered biologicals.

Main Methods:

• Review of current literature on craniofacial surgery advancements.
• Analysis of growth factor technology for bone regeneration applications.
• Discussion of the implications of recombinant human biologicals in clinical practice.

Main Results:

• Growth factor technology shows significant potential for enhancing bone tissue regeneration in craniofacial applications.
• Recombinant biologicals are poised to revolutionize craniofacial surgical procedures.
• Careful review of biological factors is crucial for advancing the field.

Conclusions:

• Recombinant human biologicals, especially growth factors, will profoundly impact craniofacial surgery.
• The integration of advanced biologicals offers new possibilities for treating complex craniofacial conditions.
• Continued research and evaluation are necessary to optimize the use of these technologies.